This interactive webinar will provide some of the key problems associated with failing Fontan adult and pediatric patients both before and after transplantation with international experts. Along discussion of an exemplary case, brief overviews will be provided on the current knowledge on protein losing enteropathy, elevated pulmonary vascular pressures, ventricular assist device options and liver assessment and consideration of combined heart liver transplantation followed by open discussion of each point and panel discussion of any other arising questions towards the end of the session.
This is webinar is organized as an interactive session. Please click here
to review questions that will be discussed during the webinar.
Simon Urschel, MD and Caron Burch, RN, MSN, FNP, CCTC
CASE PRESENTATION: Young Adult with Failing Fontan
Neha Bansal, MD, Children’s Hospital at Montefiore, Bronx, NY, USA
This case will describe a young adult with hypoplastic left heart syndrome, failing Fontan, protein losing enteropathy, hepatopathy, borderline pulmonary vascular resistance, HLA sensitization.
Related Professional Communities: Pediatrics, Pharmacy, Research/Immunology, Infectious Disease, Anesthesiology and Critical Care, Nursing and Allied Health, Pathology
Protein Losing Enteropathy in Fontan Patients: Diagnostics, Therapy, Transplant Outcomes
Kurt Schumacher, MD, University of Michigan, Ann Arbor, MI, USA
This talk will address the following question: How do you manage protein losing enteropathy in failing Fontan patients?
Related Professional Communities: Cardiology, Pediatrics, Pharmacy, Infectious Disease, Research/Immunology, Nursing and Allied Health, Pathology
Elevated Pulmonary Vascular Resistance in Fontan Patients: Diagnostics, Therapy and Impact on Transplant
Stanislav Ovroutski, MD, Berlin Heart Center, Berlin, Germany
This talk will address the following question: How do you assess and address pulmonary vascular resistance in failing Fontan patients?
Related Professional Communities: Cardiology, Pediatrics, Pharmacy, Anesthesiology and Critical Care, Nursing and Allied Health
Bridging Options and Destination Therapy with VAD: Experiences, Future Options
Ari Cedars, MD, Johns Hopkins University, Baltimore, MD, USA
This talk will address the following question: Should failing Fontan patients go on a VAD?
Related Professional Communities: Cardiology, Pediatrics, Anesthesiology and Critical Care, Nursing and Allied Health
Liver Failure in Fontan Patients: Diagnostic Work-up and Heart-Liver vs. Heart only Transplantation
Sharon Chen, MD, MPH, Stanford University, Stanford, CA, USA
This talk will address the following question: How do you quantify and manage liver dysfunction in failing Fontan patients?
Related Professional Communities: Cardiology, Pediatrics, Pharmacy, Anesthesiology and Critical Care, Research and Immunology, Nursing and Allied Health
Live Q&A Segment with All Speakers
Enduring Hearts Pediatric Heart Transplant Funding Opportunities
Carolyn Salvador, Chief Executive Officer, Enduring Hearts
Continuing Education Information
– at the conclusion of this session, attendees will be able to:
- Assess key problems associated with failing Fontan adult and pediatric patients.
- Learn current knowledge on:
- protein losing enteropathy
- elevated pulmonary vascular pressures
- ventricular assist device options & liver assessment
- consideration of combined heart liver transplantation
– The target audience for the ISHLTv Webinar: Interactive Live Case Discussion
webinar includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.
Activity Designed to Change
– This activity is designed to change knowledge.
Patient Care and Medical Knowledge
– Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.
– The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.
Documenting CME Credits
– The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf.
Accreditation Statement -
The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement –
ISHLT designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 Credits
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the International Society for Heart & Lung Transplantation. Amedco LLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement –
Amedco LLC designates this virtual activity for a maximum of 1.0 ANCC contact hours for nurses.
AAPA accepts AMA PRA Category 1 Credit(s)
™ for the PRA from organizations accredited by ACCME.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education.
Transplant Coordinators Credit
As a designated Approved Provider by the American Board for Transplant Certification (ABTC), the International Society for Heart and Lung Transplantation grants up to 1 Category 1 Continuing Education Points for Transplant Coordinators (CEPTCs) for this offering. CEPTC Approval Number: 221—26.